Merit Medical Systems, Inc. (MMSI)

Merit Medical Systems Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	128.49	120.36	94.41	74.52	48.45
Depreciation & Amortization	134.65	114.73	101.29	92.2	95.78
Other Amortization	5.66	6.77	1.72	0.6	0.6
Loss (Gain) From Sale of Assets	2.05	1.49	5.41	1.8	1.3
Asset Writedown & Restructuring Costs	0.31	0.46	1.79	8.45	4.41
Loss (Gain) From Sale of Investments	-	-	0.27	0.5	-
Stock-Based Compensation	43.46	28.47	21.33	18.04	16.09
Other Operating Activities	6.1	-14.53	-11.04	-10.42	-1.58
Change in Accounts Receivable	-7.34	-13.69	-11.92	-15.12	-8.62
Change in Inventory	-21.6	-2.29	-32.11	-47.93	-25.18
Change in Accounts Payable	1.01	-2.31	-7.3	12.66	6.05
Change in Income Taxes	3.94	-2.41	-1.84	6.05	1.06
Change in Other Net Operating Assets	0.64	-16.25	-16.87	-27.06	8.85
Operating Cash Flow	297.37	220.8	145.15	114.29	147.23
Operating Cash Flow Growth	34.68%	52.12%	27.00%	-22.37%	-10.91%
Capital Expenditures	-81.72	-35.14	-34.29	-45.03	-27.94
Sale of Property, Plant & Equipment	0.3	0.01	0.63	0.07	1.04
Cash Acquisitions	-144.77	-320.18	-134.52	-6.88	-7.17
Divestitures	-	-	-	-0.97	-
Sale (Purchase) of Intangibles	-3.12	-2.9	-2.41	-3.18	-2.83
Other Investing Activities	-18.08	-10.43	-4.76	-1.41	-0.25
Investing Cash Flow	-247.39	-368.65	-175.35	-57.4	-37.16
Long-Term Debt Issued	-	-	1,199	215.21	98.42
Long-Term Debt Repaid	-	-99.06	-579.62	-260.14	-206.92
Net Debt Issued (Repaid)	-	-99.06	619.58	-44.94	-108.5
Issuance of Common Stock	28.21	40.91	15.58	20.07	21.31
Repurchase of Common Stock	-9.53	-1.59	-5.12	-2.47	-0.58
Other Financing Activities	-2.69	-0.26	-70.77	-32.92	-10.67
Financing Cash Flow	16	-60.01	559.27	-60.26	-98.44
Foreign Exchange Rate Adjustments	3.8	-2.52	-0.48	-3.83	-0.8
Net Cash Flow	69.78	-210.38	528.59	-7.19	10.83
Free Cash Flow	215.66	185.66	110.86	69.26	119.29
Free Cash Flow Growth	16.16%	67.47%	60.06%	-41.94%	0.01%
Free Cash Flow Margin	14.23%	13.69%	8.82%	6.02%	11.10%
Free Cash Flow Per Share	3.57	3.13	1.90	1.20	2.08
Cash Interest Paid	20.99	23.24	14.05	6.26	5.26
Cash Income Tax Paid	31.39	45.05	31.53	17.09	8.83
Levered Free Cash Flow	179.71	184.91	106.2	51.35	142.07
Unlevered Free Cash Flow	190.59	197.65	114.17	54.7	144.75
Change in Working Capital	-23.34	-36.95	-70.02	-71.4	-17.84

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q